Hynninen M, Wennervirta J, Leppäniemi A, Pettilä V
Department of Anesthesiology and Intensive Care Medicine, Helsinki University Central Hospital, PO Box 340, Haartmaninkatu 4, 00029 HUS Helsinki, Finland.
Langenbecks Arch Surg. 2008 Jan;393(1):81-6. doi: 10.1007/s00423-007-0160-y. Epub 2007 Mar 20.
Secondary peritonitis is still associated with high mortality, especially when multiorgan dysfunction complicates the disease. Good prognostic tools to predict long term outcome in individual patients are lacking and therefore require further study.
163 consecutive patients with secondary peritonitis were included, except those with postoperative or traumatic peritonitis. In 58 patients treated in the intensive care unit (ICU), organ dysfunction was quantified using Sequential Organ Failure Assessment (SOFA) score in the first 4 days. Predictive factors for poor outcome were evaluated in all patients. Hospital and 1-year mortality was assessed.
Hospital mortality was 19% and 1-year mortality 23%. Acute physiology and chronic health evaluation II (APACHE II), previous functional status, and sepsis category were predictive of fatal outcome in the total cohort (p = 0.034, p < 0.001, and p < 0.001). In patients treated in the ICU, advanced age and admission SOFA score were independent predictors of death (p = 0.014, p < 0.0001). The SOFA score showed the best discriminative ability for poor outcome (AuROC 0.78).
Degree of organ dysfunction measured using SOFA score was the best predictor of hospital mortality in patients suffering from secondary peritonitis.
继发性腹膜炎的死亡率仍然很高,尤其是当多器官功能障碍使病情复杂化时。目前缺乏能够预测个体患者长期预后的良好工具,因此需要进一步研究。
纳入163例连续性继发性腹膜炎患者,但不包括术后或创伤性腹膜炎患者。在58例入住重症监护病房(ICU)的患者中,在最初4天使用序贯器官衰竭评估(SOFA)评分对器官功能障碍进行量化。评估所有患者预后不良的预测因素。评估医院死亡率和1年死亡率。
医院死亡率为19%,1年死亡率为23%。急性生理与慢性健康状况评估II(APACHE II)、既往功能状态和脓毒症类别可预测整个队列的死亡结局(p = 0.034、p < 0.001和p < 0.001)。在ICU接受治疗的患者中,高龄和入院时的SOFA评分是死亡的独立预测因素(p = 0.014、p < 0.0001)。SOFA评分对不良结局的判别能力最佳(受试者工作特征曲线下面积为0.78)。
使用SOFA评分衡量的器官功能障碍程度是继发性腹膜炎患者医院死亡率最佳预测指标。